A Study of ELND002 in Patients With Relapsing Forms of Multiple Sclerosis
- First Posted Date
- 2011-03-18
- Last Posted Date
- 2015-12-14
- Lead Sponsor
- Elan Pharmaceuticals
- Target Recruit Count
- 12
- Registration Number
- NCT01318421
A Safety and Efficacy Study of ELND002 in Patients With Relapsing Forms of Multiple Sclerosis
- First Posted Date
- 2010-06-15
- Last Posted Date
- 2015-12-14
- Lead Sponsor
- Elan Pharmaceuticals
- Target Recruit Count
- 32
- Registration Number
- NCT01144351
- Locations
- 🇨🇦
Research Site, Montreal, Quebec, Canada
Ziconotide Effectiveness and Safety Trial in Patients With Chronic Severe Pain
- Conditions
- First Posted Date
- 2004-02-04
- Last Posted Date
- 2015-12-14
- Lead Sponsor
- Elan Pharmaceuticals
- Target Recruit Count
- 300
- Registration Number
- NCT00076544
- Locations
- 🇺🇸
The University of Chicago, Dept. of Surgery, Section of Neurosurgery, Chicago, Illinois, United States
🇺🇸The Center for Pain Relief, Charleston, West Virginia, United States
🇺🇸Alabama Pain Center, Huntsville, Alabama, United States
A Study to Measure the Safety and Effectiveness of Zonisamide in Subjects With Migraine Headache
- Conditions
- First Posted Date
- 2003-03-05
- Last Posted Date
- 2015-12-14
- Lead Sponsor
- Elan Pharmaceuticals
- Target Recruit Count
- 204
- Registration Number
- NCT00055484
- Locations
- 🇺🇸
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States
🇺🇸University of South Alabama Medical Ctr Department of Neurology, Mobile, Alabama, United States
🇺🇸The New England Center for Headache, Stamford, Connecticut, United States
Prialt (Ziconotide) In Severe Chronic Pain
- Conditions
- First Posted Date
- 2002-10-17
- Last Posted Date
- 2015-12-14
- Lead Sponsor
- Elan Pharmaceuticals
- Target Recruit Count
- 220
- Registration Number
- NCT00047749
- Locations
- 🇺🇸
Tennesee Valley Pain Consultants - Center For Pain Management, Huntsville, Alabama, United States
🇺🇸Abaci and Massey Pain Center, Los Gatos, California, United States
🇺🇸Pain Care Specialists, Colorado Springs, Colorado, United States
Comparison of Safety and Efficacy of Tizanidine Hydrochloride Capsules Versus Zanaflex® (Tizanidine Hydrochloride Tablets) Taken While in the Fed State (Just After a Meal) and in the Fasted State (Before a Meal) in Patients With Moderate to Severe Spasticity.
- Conditions
- First Posted Date
- 2002-10-10
- Last Posted Date
- 2015-12-14
- Lead Sponsor
- Elan Pharmaceuticals
- Target Recruit Count
- 120
- Registration Number
- NCT00047580
- Locations
- 🇺🇸
The Neurology Center, Oceanside, California, United States
🇺🇸Neurology Medical Group of Diablo Valley, Walnut Creek, California, United States
🇺🇸Northridge Neurological Center, Northridge, California, United States
Open-label Adjunctive Zonisamide for Bipolar Disorder
- Conditions
- First Posted Date
- 2002-10-10
- Last Posted Date
- 2015-12-14
- Lead Sponsor
- Elan Pharmaceuticals
- Target Recruit Count
- 20
- Registration Number
- NCT00047567